148 related articles for article (PubMed ID: 20600391)
1. Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus.
Duhen T; Herschke F; Azocar O; Druelle J; Plumet S; Delprat C; Schicklin S; Wild TF; Rabourdin-Combe C; Gerlier D; Valentin H
Virus Res; 2010 Sep; 152(1-2):115-25. PubMed ID: 20600391
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell subsets involved in type I IFN induction in mouse measles virus infection models.
Takaki H; Oshiumi H; Matsumoto M; Seya T
Int J Biochem Cell Biol; 2014 Aug; 53():329-33. PubMed ID: 24905956
[TBL] [Abstract][Full Text] [Related]
3. Cell-cell fusion induced by measles virus amplifies the type I interferon response.
Herschke F; Plumet S; Duhen T; Azocar O; Druelle J; Laine D; Wild TF; Rabourdin-Combe C; Gerlier D; Valentin H
J Virol; 2007 Dec; 81(23):12859-71. PubMed ID: 17898060
[TBL] [Abstract][Full Text] [Related]
4. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.
Takaki H; Takeda M; Tahara M; Shingai M; Oshiumi H; Matsumoto M; Seya T
J Immunol; 2013 Nov; 191(9):4740-7. PubMed ID: 24078691
[TBL] [Abstract][Full Text] [Related]
5. Measles virus receptors.
Yanagi Y; Takeda M; Ohno S; Hashiguchi T
Curr Top Microbiol Immunol; 2009; 329():13-30. PubMed ID: 19198560
[TBL] [Abstract][Full Text] [Related]
6. Measles virus targets DC-SIGN to enhance dendritic cell infection.
de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of measles revisited.
de Swart RL
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S84-8. PubMed ID: 18820585
[TBL] [Abstract][Full Text] [Related]
8. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection.
Shingai M; Inoue N; Okuno T; Okabe M; Akazawa T; Miyamoto Y; Ayata M; Honda K; Kurita-Taniguchi M; Matsumoto M; Ogura H; Taniguchi T; Seya T
J Immunol; 2005 Sep; 175(5):3252-61. PubMed ID: 16116216
[TBL] [Abstract][Full Text] [Related]
9. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus.
Shingai M; Ebihara T; Begum NA; Kato A; Honma T; Matsumoto K; Saito H; Ogura H; Matsumoto M; Seya T
J Immunol; 2007 Nov; 179(9):6123-33. PubMed ID: 17947687
[TBL] [Abstract][Full Text] [Related]
10. Measles virus receptors and tropism.
Yanagi Y; Takeda M; Ohno S; Seki F
Jpn J Infect Dis; 2006 Feb; 59(1):1-5. PubMed ID: 16495625
[TBL] [Abstract][Full Text] [Related]
11. A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.
García-León ML; Bonifaz LC; Espinosa-Torres B; Hernández-Pérez B; Cardiel-Marmolejo L; Santos-Preciado JI; Wong-Chew RM
Hum Vaccin Immunother; 2015; 11(7):1762-9. PubMed ID: 26075901
[TBL] [Abstract][Full Text] [Related]
12. Membrane dynamics and interactions in measles virus dendritic cell infections.
Avota E; Koethe S; Schneider-Schaulies S
Cell Microbiol; 2013 Feb; 15(2):161-9. PubMed ID: 22963539
[TBL] [Abstract][Full Text] [Related]
13. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration.
Condack C; Grivel JC; Devaux P; Margolis L; Cattaneo R
J Infect Dis; 2007 Aug; 196(4):541-9. PubMed ID: 17624839
[TBL] [Abstract][Full Text] [Related]
14. Systemic spread of measles virus: overcoming the epithelial and endothelial barriers.
Ludlow M; Allen I; Schneider-Schaulies J
Thromb Haemost; 2009 Dec; 102(6):1050-6. PubMed ID: 19967134
[TBL] [Abstract][Full Text] [Related]
15. Cell-to-Cell Contact and Nectin-4 Govern Spread of Measles Virus from Primary Human Myeloid Cells to Primary Human Airway Epithelial Cells.
Singh BK; Li N; Mark AC; Mateo M; Cattaneo R; Sinn PL
J Virol; 2016 Aug; 90(15):6808-6817. PubMed ID: 27194761
[TBL] [Abstract][Full Text] [Related]
16. Both type I and type III interferons are required to restrict measles virus growth in lung epithelial cells.
Taniguchi M; Yanagi Y; Ohno S
Arch Virol; 2019 Feb; 164(2):439-446. PubMed ID: 30390151
[TBL] [Abstract][Full Text] [Related]
17. Measles virus: immunomodulation and cell tropism as pathogenicity determinants.
Schneider-Schaulies S; Schneider-Schaulies J; Niewiesk S; Ter Meulen V
Med Microbiol Immunol; 2002 Oct; 191(2):83-7. PubMed ID: 12410346
[TBL] [Abstract][Full Text] [Related]
18. Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression.
Hahm B; Arbour N; Oldstone MB
Virology; 2004 Jun; 323(2):292-302. PubMed ID: 15193925
[TBL] [Abstract][Full Text] [Related]
19. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
Guillerme JB; Boisgerault N; Roulois D; Ménager J; Combredet C; Tangy F; Fonteneau JF; Gregoire M
Clin Cancer Res; 2013 Mar; 19(5):1147-58. PubMed ID: 23339127
[TBL] [Abstract][Full Text] [Related]
20. Measles virus transmission from dendritic cells to T cells: formation of synapse-like interfaces concentrating viral and cellular components.
Koethe S; Avota E; Schneider-Schaulies S
J Virol; 2012 Sep; 86(18):9773-81. PubMed ID: 22761368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
